374 related articles for article (PubMed ID: 15770222)
1. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study.
Daubioul CA; Horsmans Y; Lambert P; Danse E; Delzenne NM
Eur J Clin Nutr; 2005 May; 59(5):723-6. PubMed ID: 15770222
[TBL] [Abstract][Full Text] [Related]
2. Oligofructose promotes satiety in healthy human: a pilot study.
Cani PD; Joly E; Horsmans Y; Delzenne NM
Eur J Clin Nutr; 2006 May; 60(5):567-72. PubMed ID: 16340949
[TBL] [Abstract][Full Text] [Related]
3. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.
Nelson A; Torres DM; Morgan AE; Fincke C; Harrison SA
J Clin Gastroenterol; 2009; 43(10):990-4. PubMed ID: 19448566
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.
Promrat K; Lutchman G; Uwaifo GI; Freedman RJ; Soza A; Heller T; Doo E; Ghany M; Premkumar A; Park Y; Liang TJ; Yanovski JA; Kleiner DE; Hoofnagle JH
Hepatology; 2004 Jan; 39(1):188-96. PubMed ID: 14752837
[TBL] [Abstract][Full Text] [Related]
5. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
6. Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects.
Delzenne NM; Daubioul C; Neyrinck A; Lasa M; Taper HS
Br J Nutr; 2002 May; 87 Suppl 2():S255-9. PubMed ID: 12088526
[TBL] [Abstract][Full Text] [Related]
7. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
[TBL] [Abstract][Full Text] [Related]
8. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Abdelmalek MF; Angulo P; Jorgensen RA; Sylvestre PB; Lindor KD
Am J Gastroenterol; 2001 Sep; 96(9):2711-7. PubMed ID: 11569700
[TBL] [Abstract][Full Text] [Related]
9. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
[TBL] [Abstract][Full Text] [Related]
10. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
11. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
12. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
13. Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis.
Charatcharoenwitthaya P; Levy C; Angulo P; Keach J; Jorgensen R; Lindor KD
Liver Int; 2007 Mar; 27(2):220-6. PubMed ID: 17311617
[TBL] [Abstract][Full Text] [Related]
14. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.
Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA
Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709
[TBL] [Abstract][Full Text] [Related]
15. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary fructose on liver steatosis in overfed mule ducks.
Davail S; Rideau N; Bernadet MD; André JM; Guy G; Hoo-Paris R
Horm Metab Res; 2005 Jan; 37(1):32-5. PubMed ID: 15702436
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
[TBL] [Abstract][Full Text] [Related]
18. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Cani PD; Neyrinck AM; Maton N; Delzenne NM
Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans.
Forcheron F; Beylot M
Metabolism; 2007 Aug; 56(8):1093-8. PubMed ID: 17618955
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
Yakaryilmaz F; Guliter S; Savas B; Erdem O; Ersoy R; Erden E; Akyol G; Bozkaya H; Ozenirler S
Intern Med J; 2007 Apr; 37(4):229-35. PubMed ID: 17388862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]